Language selection

Search


Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration.HP5-141/1-1-2022E-PDF ; HP5-141/2-1-2022E-PDF

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.917987&sl=0

Publication information
Department/Agency
  • Public Health Agency of Canada, issuing body.
  • Canada. National Advisory Committee on Immunization, issuing body.
TitleUpdated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration.
Publication typeMonograph
Language[English]
Other language editions[French]
Earlier editionRecommendations on the use of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age.
FormatDigital text
Electronic document
Note(s)
  • Issued also in French under title: Recommandations mises à jour sur l'utilisation des doses de rappel du vaccin contre la COVID-19 chez les enfants de 5 à 11 ans et sur l'administration concomitante de vaccins.
  • On cover: An advisory committee statement (ACS), National Advisory Committee on Immunization (NACI).
  • "Pub.: 220625."
  • "Pub.: 220627."
  • Includes bibliographical references (pages 18-24).
Publishing information
  • Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, December 9, 2022.
  • ©2022
Description1 online resource (24 pages) + summary (5 pages)
ISBN9780660465814 9780660465821
Catalogue number
  • HP5-141/1-1-2022E-PDF
  • HP5-141/2-1-2022E-PDF
Departmental catalogue number220625 220627
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details